Larimar Therapeutics Insider Trades

LRMR

Track insider trading activity from Larimar Therapeutics executives and directors. See which insiders are buying and selling LRMR stock.

Trades Last 12 Months

All Insider Trades for Larimar Therapeutics

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Leff Jonathan S Director
Holding Value $203k 55,150 shares
Last Trade
May 19, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$184k 55,150 shares
$3.33
$3.68
Holding Value $203k 55,150 shares
Last Trade
May 19, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$184k 55,150 shares
$3.33
$3.68
Thomas Frank E Director
Holding Value $203k 55,150 shares
Last Trade
May 19, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$184k 55,150 shares
$3.33
$3.68
Truitt Joseph Director
Holding Value $203k 55,150 shares
Last Trade
May 19, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$184k 55,150 shares
$3.33
$3.68
Holding Value $203k 55,150 shares
Last Trade
May 19, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$184k 55,150 shares
$3.33
$3.68
Flynn James E 10% owner, other, * Director By Deputization
Holding Value $203k 55,150 shares
Last Trade
May 19, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$184k 55,150 shares
$3.33
$3.68
Shankar Gopi Chief Development Officer
Holding Value $566k 153,822 shares
Last Trade
Jan 26, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$646k 179,459 shares
$3.60
$3.68
Celano Michael Chief Financial Officer
Holding Value $830k 225,622 shares
Last Trade
Jan 26, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$948k 263,226 shares
$3.60
$3.68
Ben Maimon Carole President And CEO
Holding Value $1.36M 368,276 shares
Last Trade
Jan 26, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$360k 100,100 shares
$3.60
$3.68
Clayton Russell Chief Medical Officer
Holding Value $566k 153,822 shares
Last Trade
Jan 26, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$646k 179,459 shares
$3.60
$3.68
Ben Maimon Carole President And CEO
Holding Value $2.01M 546,000 shares
Last Trade
Jan 22, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.89M 546,000 shares
$3.46
$3.68
Holding Value $30.5k 8,300 shares
Last Trade
May 10, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$24.3k 8,300 shares
$2.92
$3.68
Barrett Peter Director
Holding Value $30.5k 8,300 shares
Last Trade
May 10, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$24.3k 8,300 shares
$2.92
$3.68
Daniel Thomas O Director
Holding Value $30.5k 8,300 shares
Last Trade
May 12, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$85.8k 8,300 shares
$10.34
$3.68
Holding Value $29.4 8 shares
Last Trade
Jun 26, 2020 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$79.2M 6,091,242 shares
$13.00
$3.68
Holding Value $99.4k 27,000 shares
Last Trade
Jun 26, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$33.8k 27,000 shares
$1.25
$3.68
Everett Wendy Director
Holding Value $99.4k 27,000 shares
Last Trade
Jun 26, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$33.8k 27,000 shares
$1.25
$3.68
Perez Robert J Director
Holding Value $99.4k 27,000 shares
Last Trade
Jun 26, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$33.8k 27,000 shares
$1.25
$3.68
Lamattina John L Director
Holding Value $99.4k 27,000 shares
Last Trade
Jun 26, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$33.8k 27,000 shares
$1.25
$3.68
Singhal Priya Head Of Research & Development
Holding Value $1.38M 375,000 shares
Last Trade
Apr 02, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.08M 375,000 shares
$2.89
$3.68

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up